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Comment on “Germinal Center
Helper T Cells Are Dual Functional
Regulatory Cells with Suppressive
Activity to Conventional CD4
T Cells”
M arinova et al. (1) show that germinal center (GC)CD4CD57 T cells represent a novel populationof regulatory T cells that express CTLA-4 and glu-
cocorticoid-induced TNF1 receptor but not FOXP3. Although
they help GC B cells, these cells inhibit CD4CD57
memory/effector T cells via IL-10, TGF-, and CD95-
CD95L interaction. In 2005, Kim et al. (2) showed that
CD4CD45ROCD45RACD57CCR7CXCR5 T cells
in the GC of human lymphoid tissues comprise the major T cell
subset that helps GCB cells produce immunoglobulins, acting via
CD40L.
However, contrary evidence exists. In 1995, Bouzahah et al.
(3) showed that human tonsillar CD4CD57 T cells, which
mainly occupy the light zones of the GC where few B cells di-
vide, did not markedly enhance B cell proliferation, contrary to
GC CD4CD57 T cells. In 1996, Andersson et al. (4)
showed that the addition of exogenous IL-2 was required for
induction of Ig production by CD4CD57GChelper T cells
in vitro, although these cells spontaneously rescued GC B cells
from cell death.
In 2006, Rasheed et al. (5) showed that in GC T cells from
human tonsils, differences in stimulatory activity and CXCL13
secretion were related only to the expression levels of the ho-
meostatic chemokine receptor CXCR5 and the costimulatory
molecule ICOS, indicating that CD57 does not serve as a sur-
rogate marker for helper activity. Even if we agree that the mor-
phological interrelations between CD4CD57 GC T cells
and follicular dendritic cells (as first described in 1989 by Yuda
et al. (6)) and the appearance of CD57 cells during the tran-
sition from the primary follicle to the GC can be misleading,
Marinova et al. should havemade clear to readers that they were
investigating a cell population that lacks the optimal surrogate
markers for GC B cell help.
Daniele Focosi and Mario Petrini
Division of Hematology
Azienda Ospedaliera Universitaria Santa Chiara
Pisa, Italy
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Response to Comment on
“Germinal Center Helper T Cells
Are Dual Functional Regulatory
Cells with Suppressive Activity to
Conventional CD4 T Cells”
I t seems that Drs. Focosi and Petrini (1) classify T cells ashelpers for B cells only when they are able to promote Bcell proliferation. It is common knowledge that there are at
least two different types of Th signals during T-dependent Ag-
driven B cell activation and differentiation: 1) helper signals for
the initial B cell activation, which mainly takes place in the T-B
junction and initiates B cell proliferation; and 2) helper signals
for B cell functional maturation, which mainly takes place in
the germinal center (GC) and promotes B cell differentiation
such as class switching and memory cell development. It has
been generally accepted that GC helper T cells are critical for
the survival of B cell clones that have a competitive advantage
for limited Ags, leading to clonal selection and affinity matura-
tion (2–4). Our work (5) and another publication (6) cited in
the letter of Drs. Focosi and Petrini were about T helpers for the
GC pathway of B cell differentiation, showing that
CD4CD57CXCR5 T cells are the major helpers for B cell
survival and functional maturation. The work of Bouzahzah
and colleagues (7) showing enhancement of B cell proliferation
by CD4CD57 T cells but not by CD4CD57 T cells was
not contradictory to the notion that CD4CD57 T cells
mainly provide helper signals for GC reaction. The work of
Andersson and colleagues (8) studied CD57 T cells from pe-
ripheral blood, not GC T cells as quoted by Drs. Focosi and
Petrini. It should be noted that the differentiation pathways and
properties of most peripheral bloodCD57T cells are different
from those of tonsil CD57 T cells. Nevertheless, the findings
of a requirement for IL-2 and supporting B cell survival by pe-
ripheral blood CD57 T cells do not conflict with our results.
Mixed results were obtained from the work of Rasheed and col-
leagues (9) that used total tonsil B cells instead of purified GCB
cells. In addition, CXCL13 production is not exactly a good
marker for Th function. The major sources of CXCL13 in the
follicular area are stromal cells such as follicular dendritic cells.
Therefore, the publications (7–9) referred by Drs. Focosi and
Petrini as “contrary evidences” were, in fact, consistent with orCopyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00
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complementary to our findings. In addition, there are other ear-
lier publications that also demonstrated CD57 as a marker for
GC helper T cells (10–12).
Taken together, CD4CD45ROCD57CXCR5 are
currently the best available markers that define Th cells for GC
response.
Ekaterina Marinova, Shuhua Han, and Biao Zheng
Department of Immunology
Baylor College of Medicine
Houston, TX 77030
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Comment on “Characterization of
Human Lung Tumor-Associated
Fibroblasts and Their Ability to
Modulate the Activation of Tumor-
Associated T Cells”
W e read with interest the recent article by Nazareth etal. (1) reporting on the characterization of humanlung tumor-associated fibroblasts and their ability
to modulate the activation of tumor-associated T cells. We ap-
preciate the newly emerging evidence reporting the impact of
the microenvironment on tumor cells in cancer and read with
interest the new findings of the above mentioned article on the
role of fibroblasts adjacent to tumor cells.
However, we would like to point out that the reported
B7-H1 expression by Nazareth et al. (1) in tumor-associated
fibroblasts is an in vitro artifact rather than a natural expression
phenomenon. We have shown very recently (2) that both nor-
mal and tumor-associated fibroblasts obtained from the tissues
of breast cancer patients express very low levels (or none) of
B7-H1 molecule upon isolation and gradually start to express
this molecule upon in vitro culturing of these cells (up-regula-
tion from 5 to 100%). More importantly, fibroblasts ob-
tained from normal people undergoing plastic surgery also
demonstrated B7-H1 up-regulation after in vitro culture (up-
regulation from 2 to 90%). This phenomenon was found in
both fibroblasts and epithelial cells obtained fromnormal breast
as well as foreskin tissues. The B7-H1 up-regulation started
from day 1 of culture and peaked on day 10.We have associated
the in vitro induction of B7-H1 with cell proliferation because
its expression was strongly and significantly associated with the
proliferation marker Ki-67. Furthermore, the B7-H1 expres-
sion in the fibroblasts was completely diminished after arresting
the cells in the G0 phase (the B7-H1molecule was up-regulated
after in vitro reconditioning of these cells).
The molecular basis for the link between proliferation and
B7-H1 expression can be explained by the recent findings of
Parsa et al. (3) linking the Akt protein (a kinase important for
cellular proliferation) to B7-H1 up-regulation. In addition,
our previous in vivo study did not find any significant
B7-H1 expression in both normal and tumor-associated fi-
broblasts analyzed on frozen sections isolated from breast
cancer tissues as well as normal breast tissues from plastic
surgery patients (4). Similar findings were also reported by
Mazanet et al. (5), who demonstrated that B7-H1 was barely
detectable in normal untreated skin with only a few keratin-
ocytes and occasional vessels showing very weak staining. Al-
though our study was conducted on breast and skin tissues
that are different from the non-small cell lung cancer cells
reported in work by Nazareth et al. (1), we believe that up-
regulation of B7-H1 upon in vitro culture is a common fea-
ture for all types of proliferating cells (2).
Nazareth et al. (1) did not study the expression of B7-H1 in
histological sections to show an association of this molecule
with the tumor-associated fibroblasts. Study of the expression
of B7-H1 molecule in vitro does not reflect the actual situation
in the cancer patient. Therefore, we believe that such cultured
cells obtained from normal tissue with similar or close passage
numbers are the right controls for cultured cells obtained from
cancer tissues.
Hazem Ghebeh and Said Dermime
Tumor Immunology Unit
Department of Biological and Medical Research
King Faisal Specialist Hospital and Research Center
Riyadh, Saudi Arabia
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Response to Comment on
“Characterization of Human Lung
Tumor-Associated Fibroblasts and
Their Ability to Modulate the
Activation of Tumor-Associated T
Cells”
W e have two independently derived sets of new datathat establish that B7-H1 is expressed by fibroblastsin the microenvironment of human non-small cell
lung tumors. First, our flow cytometry data identify fibroblasts
within disrupted lung tumor biopsy tissue through staining
with a mAb specific for B7-H1 (clone MIH1). Using an Ab,
SM1214P, which is specific for a 112-kDa molecule expressed
on human fibroblasts (1–3), we confirmed that the B7-H1
cells were fibroblasts. We found that 42% of the tumor-derived
SM1214P fibroblasts expressed B7-H1 on their cell surface.
These B7-H1SM1214P cells were, as expected, negative for
CD45. Second, we demonstrated the presence of B7-H1 on tu-
mor-associated fibroblasts by immunohistochemistry of forma-
lin-fixed lung tumor tissues. Archived human lung tumor sec-
tions from our laboratory were stained in the laboratory of Dr.
Lieping Chen (Johns Hopkins University, Baltimore, MD) us-
ing his anti-B7-H1 mAb clone 5H1, which has been used suc-
cessfully to stain paraffin-embedded formalin-fixed human re-
nal cell carcinomas after Ag retrieval (4). In four of four tumors,
distinct membrane staining for B7-H1 was observed in tumor
cell subsets (Fig. 1, A and B, asterisks). In two of four tumors, a
portion of the cells with a fibroblast morphology, i.e., elongated
cells with cytoplasmic extensions and flat/oval nuclei, stained
positively with 5H1 (Fig. 1B, arrows). No staining of fibroblasts
or tumor cells was observed with an isotype-matched control
Ab (Fig. 1C). A trichrome stain of serial sections supports our
assumption that these B7-H1 cells were in fact fibroblasts
(Fig. 1A). These data confirm our reported results that tumor-
associated fibroblasts express B7-H1 on their surface in situ (5)
and that this expression is not the result of cell culture as sug-
gested byDrs. Ghebeh andDermime (6).We recognize that the
level of B7-H1 expression in the fibroblasts may vary from one
tumor to another and that the level may be influenced by several
different factors, including IFN-, as we reported (5).
We are pleased that Drs. Ghebeh and Dermime (6) have ex-
pressed interest in our work and appreciate their comments, which
stimulated us to lookmore closely for the B7-H1 expression in the
tumor-associated fibroblasts before in vitro culture.However, their
data that provoked their commentsmaybeopen to somequestions
for two reasons. First, the B7-H1 expression reported in their arti-
cle was based upon comparatively weak cytoplasmic staining (not
membrane staining as has been consistently reported forB7-H1 (4,
7)), and an isotype-matched control Ab was not included (8). Sec-
ond, these authors failed to use any marker to positively identify
their cells as fibroblasts either in vitro or in vivo.
The data presented in our paper extensively characterized pri-
mary cultures of tumor-associated fibroblasts phenotypically, and a
main conclusion was that this heterogeneous population of cells is
able tomodulate the response of tumor-associatedmemory T cells
to activation signals to the TCR (5). We establish here with this
new data that B7-H1 is expressed on a portion of the tumor-asso-
ciated fibroblast in situ. Therefore, this subset of cells in the tumor
stroma represents a potential regulator of T cell function in the hu-
man lung tumor microenvironment.
Michael R. Nazareth, Lori Broderick, Michelle R. Simpson-
Abelson, Raymond J. Kelleher, Jr., Sandra J. Yokota, and
Richard B. Bankert
Department of Microbiology and Immunology
Witebsky Center for Microbial Pathogenesis and Immunology
University at Buffalo, State University of New York
Buffalo, NY 14214
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Figure 1. Immunohistochemistry of human non-small cell lung tumor. Serial sections of a representative, formalin-fixed, human non-small cell lung
tumor were stained with trichrome (A), B7-H1 (B), or an isotype control Ab (C). A, Trichrome staining of collagen emphasizes the fibroblasts, spindle-
shaped cells with elongated nuclei (arrows). B, Anti-B7-H1 identifies a portion of positively-staining fibroblasts (arrows) and tumor cells that stain
positively (asterisk). C, Immunohistochemistry with an isotype-control Ab confirms the specificity of the B7-H1 Ab in immunohistochemical staining of
formalin-fixed, paraffin sections. Asterisks in each image identify nests of tumor cells in the tumor microenvironment. Magnification, 400.
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